Copyright © 2021 Pharmascimed. All Rights Reserved.
M7824
- Home
- M7824
GSK acquires Merck immunotherapy worth up to £3.2bn
- February 5, 2019
- 0
GlaxoSmithKline has signed a wide-reaching deal worth up to £3.2bn with German pharma giant Merck KGaA for the rights to a new type of immunotherapy for various difficult-to-treat cancers. Both...
Read moreTrending
Recent Posts
The coming age of biosimilars
- February 26, 2019
- 0
Novartis acquires game-changing cardiovascular therapy
- February 25, 2019
- 0
Roche buys gene therapy company Spark for $4.3bn
- February 25, 2019
- 0
AbbVie and Voyager Therapeutics in Parkinson’s Pact
- February 22, 2019
- 0